SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX), for the period ended September 30, 2008, achieved its second consecutive quarter of revenue growth since the Celution® System was introduced in the first quarter of 2008.
SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX), for the period ended September 30, 2008, achieved its second consecutive quarter of revenue growth since the Celution® System was introduced in the first quarter of 2008.
